JPMorgan analysts give multiple reasons for their shifted outlook on homebuilders, including affordability, interest rates and employment. Latest Ratings for TOL Date Firm Action From To Mar 2022 JP Morgan Upgrades Underweight Neutral Feb 2022 B of A Securities Upgrades Underperform Buy Feb 2022 Barclays Maintains Underweight View More Analyst Ratings for TOL View the…
Avian flu continues to spread with cases in cats, horses, and humans. Scientists monitor wildlife infections. Vaccine development may face challenges. read more
ICER’s 2023 report highlights five drugs with unsupported price increases, leading to $815 million in excess costs for U.S. payers. Discover key findings and trends. read more
Repare Therapeutics shares MYTHIC trial data, highlighting Lunre+Camo’s tolerability and efficacy in gynecologic cancers with FDA guidance on next steps. read more
Broadcom Inc. (AVGO) surges 20% on strong Q4 earnings, fueled by AI opportunity, joining trillion-dollar market cap club behind Tesla (TSLA). read more
Analysts maintain Overweight ratings on Costco, highlighting strong growth, e-commerce success, and upcoming membership fee increases. Latest Ratings for COST Date Firm Action From To Mar 2022 Deutsche Bank Maintains Hold Mar 2022 BMO Capital Maintains Outperform Mar 2022 Telsey Advisory Group Maintains Outperform View More Analyst Ratings for COST View the Latest Analyst Ratings…
NIO reportedly hit a milestone of 60 million battery swaps, despite growth plans and challenges ahead. read more
The U.S. Securities and Exchange Commission has reopened an investigation into Elon Musk’s brain-chip startup Neuralink, according to a letter shared by Musk on social media platform X on Thursday. read more